Rebecca Wallace

1.3k total citations
19 papers, 894 citations indexed

About

Rebecca Wallace is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Rebecca Wallace has authored 19 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Rebecca Wallace's work include Microbial Community Ecology and Physiology (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). Rebecca Wallace is often cited by papers focused on Microbial Community Ecology and Physiology (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). Rebecca Wallace collaborates with scholars based in United Kingdom, United States and Canada. Rebecca Wallace's co-authors include Csaba Szabó, Jon G. Mabley, Pál Pacher, John Anderson, D. J. Kushner, Barry Flutter, Kenth Gustafsson, Anna Capsomidis, Jonathan Fisher and Talia Gileadi and has published in prestigious journals such as Applied and Environmental Microbiology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Rebecca Wallace

19 papers receiving 845 citations

Peers

Countries citing papers authored by Rebecca Wallace

Since Specialization

Citations

This map shows the geographic impact of Rebecca Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Wallace more than expected).

Fields of papers citing papers by Rebecca Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Wallace. The network helps show where Rebecca Wallace may publish in the future.

Co-authorship network of co-authors of Rebecca Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Wallace. A scholar is included among the top collaborators of Rebecca Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Wallace. Rebecca Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma 2018 ·Cancer Research ·Karin Straathof, Barry Flutter, Rebecca Wallace, Simon Thomas, Gordon Weng-Kit Cheung, (unknown), Talia Gileadi, Jack Barton, Gary Wright, Sarah Inglott, David Edwards, Claire Barton, Karen Dyer, Nigel Westwood, (unknown), Sarita Depani, Karen Howe, Giuseppe Barone, Martin Pulé, John Anderson	19
2	Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation 2017 ·Molecular Therapy ·Anna Capsomidis, (unknown), Heleen H. Van Acker, Jonathan Fisher, Anne Marijn Kramer, (unknown), (unknown), Talia Gileadi, Rebecca Wallace, Kenth Gustafsson, Barry Flutter, John Anderson	206
3	Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells 2014 ·Clinical Cancer Research ·Jonathan Fisher, Mengyong Yan, (unknown), Lisa Carter, (unknown), (unknown), Rebecca Wallace, Barry Flutter, Anna Capsomidis, Michael Hubank, Nigel Klein, Robin E. Callard, Kenth Gustafsson, John Anderson	88
4	Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use 2013 ·Cytotherapy ·Sarah J. Albon, Christoph Mancao, Kimberly Gilmour, Geoffrey H. White, Ida Ricciardelli, (unknown), Gertjan Lugthart, Rebecca Wallace, Persis Amrolia	9
5	Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma 2012 ·Clinical & Translational Oncology ·Nourredine Himoudi, Rebecca Wallace, Kathryn L. Parsley, Kimberly Gilmour, (unknown), Karen Howe, Rong Dong, Neil J. Sebire, Antony Michalski, Adrian J. Thrasher, John Anderson	58
6	STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of TumorsIn Vitro 2012 ·Sarcoma ·Sam Behjati, Bristi Basu, Rebecca Wallace, (unknown), Neil J. Sebire, (unknown), John Anderson	9
7	Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine 2011 ·Cancer Immunology Immunotherapy ·Mengyong Yan, Nourredine Himoudi, Bristi Basu, Rebecca Wallace, Edmund Poon, Stuart Adams, (unknown), Shao‐An Xue, Natalie Wilson, Angus Dalgleish, Owen Williams, John Anderson	27
8	Migratory and Antigen Presentation Functions of IFN-Producing Killer Dendritic Cells 2009 ·Cancer Research ·Nourredine Himoudi, Mengyong Yan, Gerben Bouma, Daniel A. Morgenstern, Rebecca Wallace, (unknown), (unknown), Ayad Eddaoudi, (unknown), Nichola Cooper, John Anderson	11
9	Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D 2007 ·International Journal of Molecular Medicine ·Jon G. Mabley, Rebecca Wallace, Pál Pacher, (unknown), Csaba Szabó	43
10	Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways 2004 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Jon G. Mabley, Pál Pacher, Péter Bai, Rebecca Wallace, Sunali Goonesekera, László Virág, Garry J. Southan, Csaba Szabó	23
11	Potential role for 8‐oxoguanine DNA glycosylase in regulating inflammation 2004 ·The FASEB Journal ·Jon G. Mabley, Pál Pacher, Amitabha Deb, Rebecca Wallace, Rhoderick H. Elder, Csaba Szabó	103
12	The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis 2003 ·European Journal of Pharmacology ·Jon G. Mabley, Francisco García Soriano, Pál Pacher, György Haskó, Anita Marton, Rebecca Wallace, Andrew L. Salzman, Csaba Szabó	105
13	Description of two new species ofHalomonas:Halomonas israelensissp.nov. andHalomonas canadensissp.nov. 1995 ·Canadian Journal of Microbiology ·(unknown), Roger K. Latta, Rebecca Wallace, D. J. Kushner, Russell H. Vreeland	17
14	Nutrition of the Halophilic Archaebacterium, Haloferax volcanii 1990 ·Systematic and Applied Microbiology ·(unknown), Rebecca Wallace, D. J. Kushner	45
15	Lysis of Halobacteria in Bacto-Peptone by Bile Acids 1988 ·Applied and Environmental Microbiology ·Masahiro Kamekura, Dieter Oesterhelt, Rebecca Wallace, Peter J. Anderson, D. J. Kushner	36
16	Polyamines in moderately and extremely halophilic bacteria 1986 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Masahiro Kamekura, Susan Bardócz, Peter J. Anderson, Rebecca Wallace, D. J. Kushner	14
17	Growth of Vibrio costicola and other moderate halophiles in a chemically defined minimal medium 1985 ·Canadian Journal of Microbiology ·Masahiro Kamekura, Rebecca Wallace, Alan R. Hipkiss, D. J. Kushner	13
18	The Lipopolysaccharides of Neisseria gonorrhoeae Colony Types 1 and 4 1975 ·Canadian Journal of Biochemistry ·Malcolm B. Perry, (unknown), B. B. Diena, F. E. Ashton, Rebecca Wallace	64
19	CANDIDA MALICOLA, NOV. SP., ISOLATED FROM APPLES 1955 ·Canadian Journal of Microbiology ·(unknown), Rebecca Wallace	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact